Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity

MLA

Sebastiano Filetti, et al. “Gemcitabine-Loaded PEGylated Unilamellar Liposomes vs GEMZAR®: Biodistribution, Pharmacokinetic Features and in Vivo Antitumor Activity.” Journal of Controlled Release, vol. 144, June 2010, pp. 144–50. EBSCOhost, https://doi.org/10.1016/j.jconrel.2010.02.021.

APA

Sebastiano Filetti, Donatella Paolino, Christian Celia, Giuseppe Costante, Leda Racanicchi, Diego Russo, Michelangelo Iannone, Elena Trapasso, Massimo Fresta, Efisio Puxeddu, & Donato Cosco. (2010). Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity. Journal of Controlled Release, 144, 144–150. https://doi.org/10.1016/j.jconrel.2010.02.021

Chicago

Sebastiano Filetti, Donatella Paolino, Christian Celia, Giuseppe Costante, Leda Racanicchi, Diego Russo, Michelangelo Iannone, et al. 2010. “Gemcitabine-Loaded PEGylated Unilamellar Liposomes vs GEMZAR®: Biodistribution, Pharmacokinetic Features and in Vivo Antitumor Activity.” Journal of Controlled Release 144 (June): 144–50. doi:10.1016/j.jconrel.2010.02.021.